Finding 1166794 (2024-012)

Material Weakness Repeat Finding
Requirement
B
Questioned Costs
-
Year
2024
Accepted
2025-12-29

AI Summary

  • Core Issue: Property taxes were improperly charged as direct costs, violating compliance rules for allowable expenses in leasing agreements.
  • Impacted Requirements: Costs related to property taxes, insurance, and maintenance are unallowable under federal award guidelines for arm's length leases.
  • Recommended Follow-Up: Re-establish internal controls to monitor allowable costs and ensure accurate reconciliation of expenses with cash draws.

Finding Text

Finding: Direct charges for property taxes. Criteria: Allowable Costs/ Cost Principles (Non-profit Organization) Per the Compliance Supplement for UC programs, excessive charges for facility expenditures related to leasing agreements are not allowable. Recipients that lease facilities under an arm's length transaction are unable to incur and charge ownership-type costs to the award. This includes normal costs of ownership such as depreciation, maintenance costs, taxes, and insurance. Per the supplement, the portion of arm's length leases in which the recipient is required to pay any combination of property taxes, property insurance, and maintenance/repair costs separate from the base rental amount, are unallowable for reimbursement eligibility under the federal award. Condition and Context, and Cause: During our audit, we tested a selection of rent expense charged to the general ledger and noted that the charges included property taxes in addition to base rent. See discussion above at 2024-006 additional context/cause. Result: Amounts identified as unallowable costs per the compliance guidance have been included in the contract liability as disclosed in Note 12. See the Summary of Unallowable Costs and Questioned Costs tables for detail on page 56. Recommendation: The auditors recommend the Organization re-implement internal controls to track allowable expenditures and reconcile qualifying costs with cash draws.

Corrective Action Plan

Cayuga Centers will confer with its auditors to ensure it has a full list of general ledger (GL) transactions regarding which these findings are asserted. For finding 2024-011, Cayuga Centers will assess whether each transaction does, in fact, represent a capital cost and will assess all such costs against program requirements and other relevant background documentation. For finding 2024-012, Cayuga will review relevant lease terms and program requirements. If, upon full evaluation, Cayuga Centers concurs that such costs were improperly charged, it will address the matter with its primary funding agency as part of broader resolution of any unallowable costs. For steps to resolve the underlying control deficiency asserted or implied in this finding, please see Cayuga Centers’ response to Findings 2024-001 through 006 above.

Categories

Allowable Costs / Cost Principles

Other Findings in this Audit

  • 1166741 2024-003
    Material Weakness Repeat
  • 1166742 2024-004
    Material Weakness Repeat
  • 1166743 2024-005
    Material Weakness Repeat
  • 1166744 2024-006
    Material Weakness Repeat
  • 1166745 2024-007
    Material Weakness Repeat
  • 1166746 2024-008
    Material Weakness Repeat
  • 1166747 2024-009
    Material Weakness Repeat
  • 1166748 2024-010
    Material Weakness Repeat
  • 1166749 2024-011
    Material Weakness Repeat
  • 1166750 2024-012
    Material Weakness Repeat
  • 1166751 2024-013
    Material Weakness Repeat
  • 1166752 2024-003
    Material Weakness Repeat
  • 1166753 2024-004
    Material Weakness Repeat
  • 1166754 2024-005
    Material Weakness Repeat
  • 1166755 2024-006
    Material Weakness Repeat
  • 1166756 2024-007
    Material Weakness Repeat
  • 1166757 2024-008
    Material Weakness Repeat
  • 1166758 2024-009
    Material Weakness Repeat
  • 1166759 2024-010
    Material Weakness Repeat
  • 1166760 2024-011
    Material Weakness Repeat
  • 1166761 2024-012
    Material Weakness Repeat
  • 1166762 2024-013
    Material Weakness Repeat
  • 1166763 2024-003
    Material Weakness Repeat
  • 1166764 2024-004
    Material Weakness Repeat
  • 1166765 2024-005
    Material Weakness Repeat
  • 1166766 2024-006
    Material Weakness Repeat
  • 1166767 2024-007
    Material Weakness Repeat
  • 1166768 2024-008
    Material Weakness Repeat
  • 1166769 2024-009
    Material Weakness Repeat
  • 1166770 2024-010
    Material Weakness Repeat
  • 1166771 2024-011
    Material Weakness Repeat
  • 1166772 2024-012
    Material Weakness Repeat
  • 1166773 2024-013
    Material Weakness Repeat
  • 1166774 2024-003
    Material Weakness Repeat
  • 1166775 2024-004
    Material Weakness Repeat
  • 1166776 2024-005
    Material Weakness Repeat
  • 1166777 2024-006
    Material Weakness Repeat
  • 1166778 2024-007
    Material Weakness Repeat
  • 1166779 2024-008
    Material Weakness Repeat
  • 1166780 2024-009
    Material Weakness Repeat
  • 1166781 2024-010
    Material Weakness Repeat
  • 1166782 2024-011
    Material Weakness Repeat
  • 1166783 2024-012
    Material Weakness Repeat
  • 1166784 2024-013
    Material Weakness Repeat
  • 1166785 2024-003
    Material Weakness Repeat
  • 1166786 2024-004
    Material Weakness Repeat
  • 1166787 2024-005
    Material Weakness Repeat
  • 1166788 2024-006
    Material Weakness Repeat
  • 1166789 2024-007
    Material Weakness Repeat
  • 1166790 2024-008
    Material Weakness Repeat
  • 1166791 2024-009
    Material Weakness Repeat
  • 1166792 2024-010
    Material Weakness Repeat
  • 1166793 2024-011
    Material Weakness Repeat
  • 1166795 2024-013
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.676 UNACCOMPANIED CHILDREN PROGRAM $5.28M
93.959 BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE $260,463